Retatrutide, a novel dual stimulator of the GLP-1 binding site and glucose-dependent secreted polypeptide (GIP) binding site , is exhibiting promising results in preliminary patient trials . Ongoing https://geniusbookmarks.com/story21350664/retatrutide-emerging-research-and-possible-medical-uses